| Year |
Citation |
Score |
| 2024 |
Samra K, Peakman G, MacDougall AM, Bouzigues A, Greaves CV, Convery RS, van Swieten JC, Jiskoot L, Seelaar H, Moreno F, Sanchez-Valle R, Laforce R, Graff C, Masellis M, Tartaglia MC, et al. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia. Alzheimer's & Dementia (Amsterdam, Netherlands). 16: e12571. PMID 38623386 DOI: 10.1002/dad2.12571 |
0.32 |
|
| 2024 |
Benussi A, Premi E, Grassi M, Alberici A, Cantoni V, Gazzina S, Archetti S, Gasparotti R, Fumagalli GG, Bouzigues A, Russell LL, Samra K, Cash DM, Bocchetta M, Todd EG, ... ... Laforce RJ, et al. Diagnostic accuracy of research criteria for prodromal frontotemporal dementia. Alzheimer's Research & Therapy. 16: 10. PMID 38216961 DOI: 10.1186/s13195-024-01383-1 |
0.32 |
|
| 2023 |
Bernard-Arevalo SP, Laforce RJ, Khayat O, Bouchard V, Bruneau MA, Brunelle S, Caron S, Chamelian L, Chénard M, Côté JF, Crépeau-Gendron G, Doré MC, Fortin MP, Gagnon N, Gagnon PR, et al. Clinical Assessment of Judgment in Adults and the Elderly: Development and Validation of the Three Domains of Judgment Test-Clinical Version (3DJT-CV). Journal of Clinical Medicine. 12. PMID 37297934 DOI: 10.3390/jcm12113740 |
0.577 |
|
| 2023 |
Premi E, Pengo M, Mattioli I, Cantoni V, Dukart J, Gasparotti R, Buratti E, Padovani A, Bocchetta M, Todd EG, Bouzigues A, Cash DM, Convery RS, Russell LL, Thomas DL, ... ... Laforce R, et al. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study. Neurobiology of Disease. 179: 106068. PMID 36898614 DOI: 10.1016/j.nbd.2023.106068 |
0.306 |
|
| 2023 |
Jiskoot LC, Russell LL, Peakman G, Convery RS, Greaves CV, Bocchetta M, Poos JM, Seelaar H, Giannini LAA, van Swieten JC, van Minkelen R, Pijnenburg YAL, Rowe JB, Borroni B, Galimberti D, ... ... Laforce R, et al. The Benson Complex Figure Test detects deficits in visuoconstruction and visual memory in symptomatic familial frontotemporal dementia: A GENFI study. Journal of the Neurological Sciences. 446: 120590. PMID 36812822 DOI: 10.1016/j.jns.2023.120590 |
0.315 |
|
| 2022 |
Whiteside DJ, Malpetti M, Jones PS, Ghosh BCP, Coyle-Gilchrist I, van Swieten JC, Seelaar H, Jiskoot L, Borroni B, Sanchez-Valle R, Moreno F, Laforce R, Graff C, Synofzik M, Galimberti D, et al. Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36377606 DOI: 10.1002/alz.12824 |
0.331 |
|
| 2022 |
Staffaroni AM, Quintana M, Wendelberger B, Heuer HW, Russell LL, Cobigo Y, Wolf A, Goh SM, Petrucelli L, Gendron TF, Heller C, Clark AL, Taylor JC, Wise A, Ong E, ... ... Laforce R, et al. Temporal order of clinical and biomarker changes in familial frontotemporal dementia. Nature Medicine. PMID 36138153 DOI: 10.1038/s41591-022-01942-9 |
0.589 |
|
| 2022 |
Bernier PJ, Gourdeau C, Carmichael PH, Beauchemin JP, Voyer P, Hudon C, Laforce R. It's all about cognitive trajectory: accuracy of the cognitive charts-MoCA in normal aging, MCI, and dementia. Journal of the American Geriatrics Society. PMID 36102601 DOI: 10.1111/jgs.18029 |
0.344 |
|
| 2022 |
Ottoy J, Ozzoude M, Zukotynski K, Adamo S, Scott C, Gaudet V, Ramirez J, Swardfager W, Cogo-Moreira H, Lam B, Bhan A, Mojiri P, Kang MS, Rabin JS, Kiss A, ... ... Laforce RJ, et al. Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36047604 DOI: 10.1002/alz.12750 |
0.379 |
|
| 2022 |
Poos JM, MacDougall A, van den Berg E, Jiskoot LC, Papma JM, van der Ende EL, Seelaar H, Russell LL, Peakman G, Convery R, Pijnenburg YAL, Moreno F, Sanchez-Valle R, Borroni B, Laforce R, et al. Longitudinal Cognitive Changes in Genetic Frontotemporal Dementia Within the GENFI Cohort. Neurology. PMID 35483895 DOI: 10.1212/WNL.0000000000200384 |
0.347 |
|
| 2022 |
Bouzigues A, Russell LL, Peakman G, Bocchetta M, Greaves CV, Convery RS, Todd E, Rowe JB, Borroni B, Galimberti D, Tiraboschi P, Masellis M, Tartaglia MC, Finger E, van Swieten JC, ... ... Laforce R, et al. Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations. Journal of Neurology. PMID 35348856 DOI: 10.1007/s00415-022-11068-0 |
0.309 |
|
| 2022 |
Poos JM, Moore KM, Nicholas J, Russell LL, Peakman G, Convery RS, Jiskoot LC, van der Ende E, van den Berg E, Papma JM, Seelaar H, Pijnenburg YAL, Moreno F, Sanchez-Valle R, Borroni B, ... Laforce R, et al. Cognitive composites for genetic frontotemporal dementia: GENFI-Cog. Alzheimer's Research & Therapy. 14: 10. PMID 35045872 DOI: 10.1186/s13195-022-00958-0 |
0.334 |
|
| 2021 |
Ossenkoppele R, Singleton EH, Groot C, Dijkstra AA, Eikelboom WS, Seeley WW, Miller B, Laforce RJ, Scheltens P, Papma JM, Rabinovici GD, Pijnenburg YAL. Research Criteria for the Behavioral Variant of Alzheimer Disease: A Systematic Review and Meta-analysis. Jama Neurology. PMID 34870696 DOI: 10.1001/jamaneurol.2021.4417 |
0.616 |
|
| 2021 |
de la Sablonnière J, Tastevin M, Lavoie M, Laforce R. Longitudinal Changes in Cognition, Behaviours, and Functional Abilities in the Three Main Variants of Primary Progressive Aphasia: A Literature Review. Brain Sciences. 11. PMID 34573229 DOI: 10.3390/brainsci11091209 |
0.303 |
|
| 2021 |
Franklin HD, Russell LL, Peakman G, Greaves CV, Bocchetta M, Nicholas J, Poos J, Convery RS, Cash DM, van Swieten J, Jiskoot L, Moreno F, Sanchez-Valle R, Borroni B, Laforce R, et al. The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort. Alzheimer's Research & Therapy. 13: 127. PMID 34253227 DOI: 10.1186/s13195-021-00865-w |
0.325 |
|
| 2021 |
Stiffel M, Bergeron D, Mourabit Amari K, Poulin É, Roberge X, Meilleur-Durand S, Sellami L, Molin P, Nadeau Y, Fortin MP, Caron S, Poulin S, Verret L, Bouchard RW, Teunissen C, ... Laforce RJ, et al. Use of Alzheimer's disease cerebrospinal fluid biomarkers in a tertiary-care memory clinic. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-23. PMID 33845924 DOI: 10.1017/cjn.2021.67 |
0.708 |
|
| 2021 |
Rojas JC, Wang P, Staffaroni AM, Heller C, Cobigo Y, Wolf A, Goh SM, Ljubenkov PA, Heuer HW, Fong JC, Taylor JB, Veras E, Song L, Jeromin A, Hanlon D, ... ... Laforce R, et al. Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration. Neurology. PMID 33827960 DOI: 10.1212/WNL.0000000000011848 |
0.525 |
|
| 2020 |
Malpetti M, Jones PS, Tsvetanov KA, Rittman T, van Swieten JC, Borroni B, Sanchez-Valle R, Moreno F, Laforce R, Graff C, Synofzik M, Galimberti D, Masellis M, Tartaglia MC, Finger E, et al. Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33316852 DOI: 10.1002/alz.12252 |
0.324 |
|
| 2020 |
Gravel A, Hudon C, Meilleur-Durand S, Sellami L, Bergeron D, Paradis A, Verret L, Fortin MP, Poulin S, Macoir J, Bouchard RW, Laforce R. Validation of the Dépistage Cognitif de Québec in the Oldest Old. Canadian Geriatrics Journal : Cgj. 23: 283-288. PMID 33282048 DOI: 10.5770/cgj.23.432 |
0.722 |
|
| 2020 |
Tsvetanov KA, Gazzina S, Jones PS, van Swieten J, Borroni B, Sanchez-Valle R, Moreno F, Laforce R, Graff C, Synofzik M, Galimberti D, Masellis M, Tartaglia MC, Finger E, Vandenberghe R, et al. Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33215845 DOI: 10.1002/alz.12209 |
0.339 |
|
| 2020 |
Bergeron D, Sellami L, Poulin S, Verret L, Bouchard RW, Laforce R. The Behavioral/Dysexecutive Variant of Alzheimer's Disease: A Case Series with Clinical, Neuropsychological, and FDG-PET Characterization. Dementia and Geriatric Cognitive Disorders. 1-8. PMID 33207355 DOI: 10.1159/000511210 |
0.739 |
|
| 2020 |
Montreuil S, Poulin E, Bergeron D, Sellami L, Verret L, Fortin MP, Poulin S, Macoir J, Hudon C, Bouchard RW, Lavoie M, Laforce R. Cognitive Profile of the Logopenic Variant of Primary Progressive Aphasia Using the Dépistage Cognitif de Québec. Dementia and Geriatric Cognitive Disorders. 1-8. PMID 33113530 DOI: 10.1159/000510501 |
0.742 |
|
| 2020 |
Bergeron D, Beauregard JM, Soucy JP, Verret L, Poulin S, Matias-Guiu JA, Cabrera-Martín MN, Bouchard RW, Laforce R. Posterior Cingulate Cortex Hypometabolism in Non-Amnestic Variants of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32925054 DOI: 10.3233/Jad-200567 |
0.732 |
|
| 2020 |
Convery RS, Bocchetta M, Greaves CV, Moore KM, Cash DM, Van Swieten J, Moreno F, Sánchez-Valle R, Borroni B, Laforce R, Masellis M, Tartaglia MC, Graff C, Galimberti D, Rowe JB, et al. Abnormal pain perception is associated with thalamo-cortico-striatal atrophy in expansion carriers in the GENFI cohort. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32759310 DOI: 10.1136/Jnnp-2020-323279 |
0.304 |
|
| 2020 |
Ismail Z, Black SE, Camicioli R, Chertkow H, Herrmann N, Laforce R, Montero-Odasso M, Rockwood K, Rosa-Neto P, Seitz D, Sivananthan S, Smith EE, Soucy JP, Vedel I, Gauthier S, et al. Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32725777 DOI: 10.1002/Alz.12105 |
0.468 |
|
| 2020 |
Zukotynski K, Gaudet V, Kuo PH, Adamo S, Goubran M, Scott CJM, Bocti C, Borrie M, Chertkow H, Frayne R, Hsiung R, Laforce R, Noseworthy MD, Prato FS, Sahlas DJ, et al. The Use of Random Forests to Identify Brain Regions on Amyloid and FDG PET Associated With MoCA Score. Clinical Nuclear Medicine. 45: 427-433. PMID 32366785 DOI: 10.1097/Rlu.0000000000003043 |
0.355 |
|
| 2020 |
van der Ende EL, Xiao M, Xu D, Poos JM, Panman JL, Jiskoot LC, Meeter LH, Dopper EG, Papma JM, Heller C, Convery R, Moore K, Bocchetta M, Neason M, Peakman G, ... ... Laforce R, et al. Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32273328 DOI: 10.1136/Jnnp-2019-322493 |
0.319 |
|
| 2020 |
Beaudin M, Sellami L, Martel C, Touzel-Deschênes L, Houle G, Martineau L, Lacroix K, Lavallée A, Chrestian N, Rouleau GA, Gros-Louis F, Laforce R, Dupré N. Characterization of the phenotype with cognitive impairment and protein mislocalization in SCA34. Neurology. Genetics. 6: e403. PMID 32211516 DOI: 10.1212/Nxg.0000000000000403 |
0.378 |
|
| 2020 |
Ducharme S, Dols A, Laforce R, Devenney E, Kumfor F, van den Stock J, Dallaire-Théroux C, Seelaar H, Gossink F, Vijverberg E, Huey E, Vandenbulcke M, Masellis M, Trieu C, Onyike C, et al. Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. Brain : a Journal of Neurology. PMID 32129844 DOI: 10.1093/Brain/Awaa018 |
0.4 |
|
| 2020 |
Moore K, Convery R, Bocchetta M, Neason M, Cash DM, Greaves C, Russell LL, Clarke MTM, Peakman G, van Swieten J, Jiskoot L, Moreno F, Barandiaran M, Sanchez-Valle R, Borroni B, ... Laforce R, et al. A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort. Applied Neuropsychology. Adult. 1-8. PMID 32024404 DOI: 10.1080/23279095.2020.1716357 |
0.361 |
|
| 2020 |
Heller C, Foiani MS, Moore K, Convery R, Bocchetta M, Neason M, Cash DM, Thomas D, Greaves CV, Woollacott IO, Shafei R, Van Swieten JC, Moreno F, Sanchez-Valle R, Borroni B, ... Laforce R, et al. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31937580 DOI: 10.1136/Jnnp-2019-321954 |
0.346 |
|
| 2019 |
Sudre CH, Bocchetta M, Heller C, Convery R, Neason M, Moore KM, Cash DM, Thomas DL, Woollacott IOC, Foiani M, Heslegrave A, Shafei R, Greaves C, van Swieten J, Moreno F, ... ... Laforce R, et al. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study. Neuroimage. Clinical. 24: 102077. PMID 31835286 DOI: 10.1016/J.Nicl.2019.102077 |
0.353 |
|
| 2019 |
Moore KM, Nicholas J, Grossman M, McMillan CT, Irwin DJ, Massimo L, Van Deerlin VM, Warren JD, Fox NC, Rossor MN, Mead S, Bocchetta M, Boeve BF, Knopman DS, Graff-Radford NR, ... ... Laforce R, et al. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. The Lancet. Neurology. PMID 31810826 DOI: 10.1016/S1474-4422(19)30394-1 |
0.337 |
|
| 2019 |
van der Ende EL, Meeter LH, Poos JM, Panman JL, Jiskoot LC, Dopper EGP, Papma JM, de Jong FJ, Verberk IMW, Teunissen C, Rizopoulos D, Heller C, Convery RS, Moore KM, Bocchetta M, ... ... Laforce R, et al. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study. The Lancet. Neurology. 18: 1103-1111. PMID 31701893 DOI: 10.1016/S1474-4422(19)30354-0 |
0.348 |
|
| 2019 |
Tavares TP, Mitchell DGV, Coleman K, Shoesmith C, Bartha R, Cash DM, Moore KM, van Swieten J, Borroni B, Galimberti D, Tartaglia MC, Rowe J, Graff C, Tagliavini F, Frisoni G, ... ... Laforce R, et al. Ventricular volume expansion in presymptomatic genetic frontotemporal dementia. Neurology. PMID 31578297 DOI: 10.1212/Wnl.0000000000008386 |
0.331 |
|
| 2019 |
Sellami L, St-Onge F, Poulin S, Laforce R. Schizophrenia Phenotype Preceding Behavioral Variant Frontotemporal Dementia Related to C9orf72 Repeat Expansion. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 32: 120-123. PMID 31205123 DOI: 10.1097/Wnn.0000000000000189 |
0.629 |
|
| 2019 |
Montembeault M, Chapleau M, Jarret J, Boukadi M, Laforce R, Wilson MA, Rouleau I, Brambati SM. Differential language network functional connectivity alterations in Alzheimer's disease and the semantic variant of primary progressive aphasia. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 117: 284-298. PMID 31034993 DOI: 10.1016/J.Cortex.2019.03.018 |
0.337 |
|
| 2019 |
Bouchard LO, Wilson MA, Laforce R, Duchesne S. White Matter Damage in the Semantic Variant of Primary Progressive Aphasia. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-10. PMID 31030675 DOI: 10.1017/Cjn.2019.37 |
0.31 |
|
| 2019 |
van der Ende EL, Meeter LH, Stingl C, van Rooij JGJ, Stoop MP, Nijholt DAT, Sanchez-Valle R, Graff C, Öijerstedt L, Grossman M, McMillan C, Pijnenburg YAL, Laforce R, Binetti G, Benussi L, et al. Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics. Annals of Clinical and Translational Neurology. 6: 698-707. PMID 31019994 DOI: 10.1002/Acn3.745 |
0.346 |
|
| 2019 |
Mutsaerts HJMM, Mirza SS, Petr J, Thomas DL, Cash DM, Bocchetta M, de Vita E, Metcalfe AWS, Shirzadi Z, Robertson AD, Tartaglia MC, Mitchell SB, Black SE, Freedman M, Tang-Wai D, ... ... Laforce R, et al. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study. Brain : a Journal of Neurology. PMID 30847466 DOI: 10.1093/Brain/Awz039 |
0.343 |
|
| 2019 |
Rittman T, Borchert R, Jones S, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Graff C, Tagliavini F, Frisoni GB, Laforce R, Finger E, Mendonça A, Sorbi S, et al. Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia. Neurobiology of Aging. 77: 169-177. PMID 30831384 DOI: 10.1016/J.Neurobiolaging.2018.12.009 |
0.374 |
|
| 2019 |
Premi E, Calhoun VD, Diano M, Gazzina S, Cosseddu M, Alberici A, Archetti S, Paternicò D, Gasparotti R, van Swieten J, Galimberti D, Sanchez-Valle R, Laforce R, Moreno F, Synofzik M, et al. The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint. Neuroimage. PMID 30716457 DOI: 10.1016/J.Neuroimage.2019.01.080 |
0.357 |
|
| 2019 |
Malpetti M, Kievit RA, Jones PS, Rittman T, Tsvetanov KA, van Swieten JC, Borroni B, Galimberti D, Sanchez-Valle R, Laforce R, Moreno F, Synofzik M, Graff C, Masellis M, Tartaglia C, et al. O4-03-06: LONGITUDINAL ASSOCIATION BETWEEN APATHY AND COGNITIVE DECLINE IN PRE- AND POST-SYMPTOMATIC GENETIC FRONTOTEMPORAL DEMENTIA Alzheimer's & Dementia. 15: P1237-P1237. DOI: 10.1016/J.Jalz.2019.06.4757 |
0.424 |
|
| 2019 |
Leijenaar JF, Groot C, Sudre CH, Bergeron D, Leeuwis AE, Cardoso J, Carrasco FP, Laforce R, Barkhof F, Flier WMvd, Scheltens P, Prins ND, Ossenkoppele R. COMORBID AMYLOID-β PATHOLOGY AFFECTS NEUROPSYCHIATRIC, NEUROPSYCHOLOGICAL, AND IMAGING FEATURES IN VASCULAR COGNITIVE DISORDERS Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4647 |
0.366 |
|
| 2019 |
St-Onge F, Coulombe V, Meilleur-Durand S, Lévesque M, Sellami L, Paquette-Raynard E, Laforce R. P2-362: IMAGING CHARACTERISTICS OF PRE-SYMPTOMATIC FAMILIAL FRONTOTEMPORAL DEMENTIA: A SYSTEMATIC REVIEW (PROTOCOL) Alzheimer's & Dementia. 15: P738-P739. DOI: 10.1016/J.Jalz.2019.06.2769 |
0.335 |
|
| 2018 |
Cury C, Durrleman S, Cash DM, Lorenzi M, Nicholas JM, Bocchetta M, van Swieten JC, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, ... Laforce R, et al. Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort. Neuroimage. 188: 282-290. PMID 30529631 DOI: 10.1016/J.Neuroimage.2018.11.063 |
0.361 |
|
| 2018 |
Sellami L, Meilleur-Durand S, Chouinard AM, Bergeron D, Verret L, Poulin S, Jean L, Fortin MP, Nadeau Y, Molin P, Caron S, Macoir J, Hudon C, Bouchard RW, Laforce R. The Dépistage Cognitif de Québec: A New Clinician's Tool for Early Recognition of Atypical Dementia. Dementia and Geriatric Cognitive Disorders. 46: 310-321. PMID 30481754 DOI: 10.1159/000494348 |
0.767 |
|
| 2018 |
Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, Cash DM, Thomas DL, Dick KM, Cardoso J, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, ... ... Laforce R, et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nature Communications. 9: 4273. PMID 30323170 DOI: 10.1038/S41467-018-05892-0 |
0.36 |
|
| 2018 |
Jiskoot LC, Bocchetta M, Nicholas JM, Cash DM, Thomas D, Modat M, Ourselin S, Rombouts SARB, Dopper EGP, Meeter LH, Panman JL, van Minkelen R, van der Ende EL, Donker Kaat L, Pijnenburg YAL, ... ... Laforce R, et al. Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross-sectional diffusion tensor imaging study. Annals of Clinical and Translational Neurology. 5: 1025-1036. PMID 30250860 DOI: 10.1002/Acn3.601 |
0.302 |
|
| 2018 |
Laforce R, Soucy JP, Sellami L, Dallaire-Théroux C, Brunet F, Bergeron D, Miller BL, Ossenkoppele R. Molecular imaging in dementia: Past, present, and future. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30028955 DOI: 10.1016/J.Jalz.2018.06.2855 |
0.478 |
|
| 2018 |
Hsu S, Gordon BA, Hornbeck R, Norton JB, Levitch D, Louden A, Ziegemeier E, Laforce R, Chhatwal J, Day GS, McDade E, Morris JC, Fagan AM, Benzinger TLS, Goate AM, et al. Discovery and validation of autosomal dominant Alzheimer's disease mutations. Alzheimer's Research & Therapy. 10: 67. PMID 30021643 DOI: 10.1186/S13195-018-0392-9 |
0.416 |
|
| 2018 |
Fumagalli GG, Basilico P, Arighi A, Bocchetta M, Dick KM, Cash DM, Harding S, Mercurio M, Fenoglio C, Pietroboni AM, Ghezzi L, van Swieten J, Borroni B, de Mendonça A, Masellis M, ... ... Laforce R, et al. Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales. Alzheimer's Research & Therapy. 10: 46. PMID 29793546 DOI: 10.1186/S13195-018-0376-9 |
0.32 |
|
| 2018 |
Meeter LHH, Gendron TF, Sias AC, Jiskoot LC, Russo SP, Donker Kaat L, Papma JM, Panman JL, van der Ende EL, Dopper EG, Franzen S, Graff C, Boxer AL, Rosen HJ, Sanchez-Valle R, ... ... Laforce R, et al. Poly(GP), neurofilament and grey matter deficits in expansion carriers. Annals of Clinical and Translational Neurology. 5: 583-597. PMID 29761121 DOI: 10.1002/Acn3.559 |
0.396 |
|
| 2018 |
Schneider R, McKeever P, Kim T, Graff C, van Swieten JC, Karydas A, Boxer A, Rosen H, Miller BL, Laforce R, Galimberti D, Masellis M, Borroni B, Zhang Z, Zinman L, et al. Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29434051 DOI: 10.1136/Jnnp-2017-317492 |
0.401 |
|
| 2018 |
Schneider R, McKeever P, Kim T, Graff C, van Swieten J, Karydas A, Boxer A, Rosen H, Miller B, Laforce R, Galimberti D, Masellis M, Borroni B, Zhang Z, Zinman L, et al. P.002 Exosomal miR-204-5 and miR-632 in CSF are candidate biomarkers for frontotemporal dementia: a GENFI study Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 45: S16-S16. DOI: 10.1017/Cjn.2018.104 |
0.373 |
|
| 2018 |
Montembeault M, Jarret J, Boukadi M, Chapleau M, Laforce R, Wilson MA, Rouleau I, Brambati SM. P1-394: Language Network Alterations In Alzheimer'S Disease And A Semantic Variant Of Primary Progressive Aphasia Patients Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.402 |
0.34 |
|
| 2017 |
Bouvier L, Monetta L, Laforce R, Verret L, Martel-Sauvageau V. L'apport critique de l'évaluation de la communication dans le diagnostic précoce de l'apraxie primaire progressive de la parole. Canadian Journal On Aging = La Revue Canadienne Du Vieillissement. 1-10. PMID 29265994 DOI: 10.1017/S0714980817000502 |
0.307 |
|
| 2017 |
Bernier PJ, Gourdeau C, Carmichael PH, Beauchemin JP, Verreault R, Bouchard RW, Kröger E, Laforce R. Validation and diagnostic accuracy of predictive curves for age-associated longitudinal cognitive decline in older adults. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 189: E1472-E1480. PMID 29203616 DOI: 10.1503/Cmaj.160792 |
0.643 |
|
| 2017 |
Bernier PJ, Gourdeau C, Carmichael PH, Beauchemin JP, Verreault R, Bouchard RW, Kröger E, Laforce R. Validation and diagnostic accuracy of predictive curves for age-associated longitudinal cognitive decline in older adults. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 189: E1472-E1480. PMID 29203616 DOI: 10.1503/Cmaj.160792 |
0.643 |
|
| 2017 |
Cash DM, Bocchetta M, Thomas DL, Dick KM, van Swieten JC, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R, Finger E, et al. Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study. Neurobiology of Aging. 62: 191-196. PMID 29172163 DOI: 10.1016/J.Neurobiolaging.2017.10.008 |
0.331 |
|
| 2017 |
Bergeron D, Poulin S, Laforce R. Cognition and anatomy of adult Niemann-Pick disease type C: Insights for the Alzheimer field. Cognitive Neuropsychology. 1-14. PMID 28662611 DOI: 10.1080/02643294.2017.1340264 |
0.67 |
|
| 2017 |
Laforce R, Sellami L, Bergeron D, Paradis A, Verret L, Fortin MP, Houde M, Roy M, Poulin S, Macoir J, Hudon C, Bouchard RW. Validation of the Dépistage Cognitif de Québec: A New Cognitive Screening Tool for Atypical Dementias. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 1-9. PMID 28541543 DOI: 10.1093/Arclin/Acx048 |
0.76 |
|
| 2017 |
Sudre CH, Bocchetta M, Cash D, Thomas DL, Woollacott I, Dick KM, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni G, ... Laforce R, et al. White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort. Neuroimage. Clinical. 15: 171-180. PMID 28529873 DOI: 10.1016/J.Nicl.2017.04.015 |
0.302 |
|
| 2017 |
Laforce R, Verret L, Poulin S, Fortin MP, Houde M. Rémi W Bouchard, a pioneer in behavioural neurology. The Lancet. Neurology. 16: 344. PMID 28414648 DOI: 10.1016/S1474-4422(17)30094-7 |
0.548 |
|
| 2017 |
Macoir J, Lavoie M, Laforce R, Brambati SM, Wilson MA. Dysexecutive Symptoms in Primary Progressive Aphasia. Journal of Geriatric Psychiatry and Neurology. 891988717700507. PMID 28355946 DOI: 10.1177/0891988717700507 |
0.362 |
|
| 2017 |
Meeter LHH, Gendron TF, Sias AC, Jiskoot LC, Graff C, Boxer AL, Sánchez-Valle R, Pijnenburg YAL, Benussi L, Ghidoni R, Borroni B, Laforce R, Cardoso MJ, Ourselin S, Cash DM, et al. Poly-Gp Dipeptide Repeats And Neurofilament Light Chain As Biomarkers In Presymptomatic And Symptomatic Frontotemporal Dementia Caused By C9Orf72 Repeat Expansions Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.425 |
0.317 |
|
| 2017 |
Mirza SS, Mutsaerts HJMM, Cash DM, Bocchetta M, Thomas DL, Dick KM, Swieten JCv, Borroni B, Galimberti D, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R, et al. Fronto-Subcortical Hypoperfusion In Presymptomatic Ftd Is Associated With Behavioral Measures, But Not Cognitive Deficits: The Genfi Study Alzheimers & Dementia. 13: 551. DOI: 10.1016/J.Jalz.2017.07.148 |
0.381 |
|
| 2017 |
Sellami L, Laforce R. [P2-316]: SCHIZOPHRENIA SPECTRUM AND BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA: THE TWO FACES OF C9ORF72 REPEAT EXPANSION? Alzheimer's & Dementia. 13: P738-P739. DOI: 10.1016/J.Jalz.2017.06.970 |
0.311 |
|
| 2017 |
Jiskoot LC, Bocchetta M, Papma JM, Nicholas JM, Cash DM, Modat M, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R, et al. Presymptomatic White Matter Integrity Loss In Familial Frontotemporal Dementia In The Genetic Frontotemporal Dementia Initiative (Genfi) Cohort: A Multi-Centre, Cross-Sectional, Diffusion Tensor Imaging Study Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.453 |
0.34 |
|
| 2017 |
Bergeron D, Vermette A, De La Sablonnière J, Cayer A, Bouchard RW, Laforce R. [P1-332]: HIDDEN IN PLAIN SIGHT: COGNITIVE INTERPRETATION OF THE FINGER-TO-NOSE TEST IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P383-P383. DOI: 10.1016/J.Jalz.2017.06.348 |
0.687 |
|
| 2017 |
Sudre CH, Bocchetta M, Cash DM, Thomas DL, Woollacott IO, Dick KM, Swieten JCv, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, ... Laforce R, et al. White Matter Hyperintensities In Genetic Frontotemporal Dementia: A Genfi Study Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2634 |
0.339 |
|
| 2017 |
Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Cash DM, Thomas DL, Dick KM, Cardoso MJ, Ourselin S, Swieten JCv, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, ... ... Laforce R, et al. Multiple Distinct Atrophy Patterns Found In Genetic Frontotemporal Dementia Using Subtype And Stage Inference (Sustain) Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2352 |
0.329 |
|
| 2017 |
Dick KM, Swieten JCv, Gerhard A, Ber IL, Frisoni GB, Dickerson BC, Graff C, Ghoshal N, Borroni B, Galimberti D, Mackenzie IR, Synofzik M, Sanchez-Valle R, Santana I, Moreno F, ... ... Laforce R, et al. Symptom Onset In Genetic Frontotemporal Dementia Alzheimers & Dementia. 13: 1337. DOI: 10.1016/J.Jalz.2017.06.2056 |
0.326 |
|
| 2017 |
Bergeron D, Sellami L, Verret L, Fortin M, Houde M, Hudon C, Poulin S, Roy M, Bouchard RW, Laforce R. [P2-445]: DÉ́PISTAGE COGNITIF DE QUÉBÉC (DCQ): VALIDATION AND NORMATIVE DATA FOR A NOVEL COGNITIVE SCREENING TOOL FOR ATYPICAL DEMENTIAS Alzheimer's & Dementia. 13: P807-P808. DOI: 10.1016/J.Jalz.2017.06.1101 |
0.761 |
|
| 2017 |
Rittman T, Borchert R, Jones PS, Swieten JCv, Borroni B, Galimberti D, Masellis M, Graff C, Tagliavini F, Frisoni GB, Laforce R, Finger E, Mendonca A, Sorbi S, Rohrer JD, et al. In Genetic Frontotemporal Dementia, Functional Network Efficiency Is Maintained Until The Onset Of Symptoms: Evidence For Functional Resilience To Structural Change Alzheimers & Dementia. 13: 244. DOI: 10.1016/J.Jalz.2017.06.096 |
0.301 |
|
| 2016 |
Callahan BL, Laforce R, Dugas M, Hudon C. Memory for emotional images differs according to the presence of depressive symptoms in individuals at risk for dementia. International Psychogeriatrics. 1-13. PMID 27974073 DOI: 10.1017/S1041610216002179 |
0.354 |
|
| 2016 |
Bergeron D, Vermette A, De La Sablonnière J, Cayer AM, Laforce R, Bouchard RW. Finger-to-Nose Test Findings in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27858718 DOI: 10.3233/Jad-160941 |
0.712 |
|
| 2016 |
Pilon MH, Poulin S, Fortin MP, Houde M, Verret L, Bouchard RW, Laforce R. Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study. Neurology (E-Cronicon). 2: 278-286. PMID 27747317 |
0.768 |
|
| 2016 |
Larouche E, Tremblay MP, Potvin O, Laforest S, Bergeron D, Laforce R, Monetta L, Boucher L, Tremblay P, Belleville S, Lorrain D, Gagnon JF, Gosselin N, Castellano CA, Cunnane SC, et al. Normative Data for the Montreal Cognitive Assessment in Middle-Aged and Elderly Quebec-French People. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 27625048 DOI: 10.1093/Arclin/Acw076 |
0.433 |
|
| 2016 |
Bensaïdane MR, Beauregard JM, Poulin S, Buteau FA, Guimond J, Bergeron D, Verret L, Fortin MP, Houde M, Bouchard RW, Soucy JP, Laforce R. Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers. Journal of Alzheimer's Disease : Jad. PMID 27104896 DOI: 10.3233/Jad-151180 |
0.766 |
|
| 2016 |
Laforce R, Bensaïdane MR, Laforce R, Bensaïdane MR, Laforce R, Bensaïdane MR. Amyloid imaging for dementia in Canada. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. PMID 27067816 DOI: 10.1503/Cmaj.150663 |
0.406 |
|
| 2016 |
Callahan BL, Simard M, Mouiha A, Rousseau F, Laforce R, Hudon C. Impact of Depressive Symptoms on Memory for Emotional Words in Mild Cognitive Impairment and Late-Life Depression. Journal of Alzheimer's Disease : Jad. PMID 27031467 DOI: 10.3233/Jad-150585 |
0.365 |
|
| 2016 |
Auclair-Ouellet N, Macoir J, Laforce R, Bier N, Fossard M. Regularity and beyond: Impaired production and comprehension of inflectional morphology in semantic dementia. Brain and Language. 155: 1-11. PMID 26994740 DOI: 10.1016/J.Bandl.2016.02.002 |
0.342 |
|
| 2016 |
Laforce R, Rosa-Neto P, Soucy JP, Rabinovici GD, Dubois B, Gauthier S. Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-10. PMID 26916179 DOI: 10.1017/Cjn.2015.401 |
0.564 |
|
| 2016 |
Kröger E, Laforce R. Fish Consumption, Brain Mercury, and Neuropathology in Patients With Alzheimer Disease and Dementia. Jama. 315: 465-6. PMID 26836728 DOI: 10.1001/Jama.2016.0005 |
0.398 |
|
| 2016 |
Auclair-Ouellet N, Fossard M, Laforce R, Bier N, Macoir J. Conception or *conceivation? The processing of derivational morphology in semantic dementia Aphasiology. 31: 166-188. DOI: 10.1080/02687038.2016.1168918 |
0.314 |
|
| 2016 |
Prins ND, Bergeron D, Groot C, Loenhoud ACv, Laforce R, Berckel BNMv, Barkhof F, Flier WMvd, Scheltens P, Ossenkoppele R. Impact Of Co-Morbid Amyloid Pathology On Clinical Phenotype Of Patients With Vascular Cognitive Disorders Alzheimers & Dementia. 12: 472. DOI: 10.1016/J.Jalz.2016.06.926 |
0.408 |
|
| 2016 |
Mutsaerts HJMM, Rohrer JD, Thomas DL, Cash DM, Vita Ed, Nicholas JM, Swieten JCv, Dopper EGP, Jiskoot LC, Minkelen Rv, Rombouts SARB, Dick KM, Bocchetta M, Cardoso MJ, Espak M, ... ... Laforce R, et al. Cerebral Perfusion As An Imaging Biomarker Of Presymptomatic Genetic Frontotemporal Dementia: Preliminary Results From The Genetic Frontotemporal Dementia Initiative (Genfi) Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.772 |
0.374 |
|
| 2016 |
Laforce R, Bensaidane MR, Beauregard J, Poulin S, Bergeron D, Verret L, Fortin M, Houde M, Soucy J, Bouchard RW. P2-394: Impact of Disclosing Amyloid Status on Caregivers: A Memory Clinic Study Alzheimer's & Dementia. 12: P796-P796. DOI: 10.1016/J.Jalz.2016.06.1605 |
0.718 |
|
| 2015 |
Bergeron D, Bensaïdane R, Laforce R. Untangling Alzheimer's disease clinicoanatomical heterogeneity through selective network vulnerability - an effort to understand a complex disease. Current Alzheimer Research. PMID 26567745 DOI: 10.2174/1567205013666151116125155 |
0.385 |
|
| 2015 |
Bergeron D, Beauregard JM, Guimond J, Fortin MP, Houde M, Poulin S, Verret L, Bouchard RW, Laforce R. Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes. Journal of Alzheimer's Disease : Jad. PMID 26484904 DOI: 10.3233/Jad-150302 |
0.715 |
|
| 2015 |
Gaudreau G, Monetta L, Macoir J, Poulin S, Laforce R, Hudon C. Mental State Inferences Abilities Contribution to Verbal Irony Comprehension in Older Adults with Mild Cognitive Impairment. Behavioural Neurology. 2015: 685613. PMID 26199459 DOI: 10.1155/2015/685613 |
0.624 |
|
| 2015 |
Rohrer JD, Nicholas JM, Cash DM, van Swieten J, Dopper E, Jiskoot L, van Minkelen R, Rombouts SA, Cardoso MJ, Clegg S, Espak M, Mead S, Thomas DL, De Vita E, Masellis M, ... ... Laforce R, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. The Lancet. Neurology. 14: 253-62. PMID 25662776 DOI: 10.1016/S1474-4422(14)70324-2 |
0.447 |
|
| 2015 |
Gaudreau G, Monetta L, Macoir J, Poulin S, Laforce RJ, Hudon C. Mental State Inferences Abilities Contribution to Verbal Irony Comprehension in Older Adults with Mild Cognitive Impairment Behavioural Neurology. 2015. DOI: 10.1155/2015/685613 |
0.587 |
|
| 2015 |
Laforce R, Bensaïdane MR, Bouchard RW, Fortin M, Houde M, Rosa-Neto P, Poulin S, Verret L, Soucy J, Beauregard J. FTS-04-03: Clinical utility of amyloid PET in the differential diagnosis of atypical dementias and its impact on caregivers Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.342 |
0.755 |
|
| 2015 |
Cash DM, Dick KM, Fellows A, Espak M, Swieten JCv, Galimberti D, Borroni B, Masellis M, Tagliavini F, Graff C, Rowe J, Frisoni GB, Laforce R, Finger E, Sorbi S, et al. MONDAY, JULY 20, 2015 ORAL SESSIONS O2-01 NEUROIMAGING: IMAGING — AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE AND FTLDGrey matter differences in genetic frontotemporal dementia: Results from the genfi study Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.130 |
0.383 |
|
| 2015 |
Bergeron D, Fortin M, Houde M, Poulin S, Roy M, Verret L, Bouchard RW, Laforce R. P2-197: Dépistage cognitif de québec (DCQ): A novel cognitive screening test for atypical dementias Alzheimer's & Dementia. 11: P568-P568. DOI: 10.1016/J.Jalz.2015.06.736 |
0.761 |
|
| 2015 |
Bensaïdane MR, Bouchard RW, Fortin M, Houde M, Neto PR, Poulin S, Verret L, Soucy J, Beauregard J, Laforce R. P1-173: Clinical utility of amyloid imaging in the differential diagnosis of atypical/unclear dementias and its impact on caregivers Alzheimer's & Dementia. 11: P411-P411. DOI: 10.1016/j.jalz.2015.06.372 |
0.632 |
|
| 2015 |
Bergeron D, Fortin M, Houde M, Poulin S, Verret L, Bouchard RW, Laforce R. P3-212: Distinct rates of cognitive decline associated with normal aging Alzheimer's & Dementia. 11: P713-P714. DOI: 10.1016/J.Jalz.2015.06.1584 |
0.736 |
|
| 2015 |
Bernier PJ, Gourdeau C, Carmichael P, Beauchemin J, Verreault R, Bouchard RW, Kröger E, Laforce R. P3-207: Applying ‘growth curves’ to age-associated cognitive decline: An innovative method to help determine normal versus abnormal longitudinal cognitive changes in the elderly Alzheimer's & Dementia. 11: P711-P712. DOI: 10.1016/J.Jalz.2015.06.1579 |
0.665 |
|
| 2015 |
Cash DM, Dick KM, Fellows A, Espak M, Swieten JCv, Galimberti D, Borroni B, Masellis M, Tagliavini F, Graff C, Rowe J, Frisoni GB, Laforce R, Finger E, Sorbi S, et al. Grey matter differences in genetic frontotemporal dementia: Results from the genfi study Alzheimers & Dementia. 11: 171. DOI: 10.1016/J.Jalz.2015.06.075 |
0.36 |
|
| 2015 |
Bensaïdane MR, Bouchard RW, Fortin M, Houde M, Neto PR, Poulin S, Verret L, Soucy J, Beauregard J, Laforce R. IC-P-007: Clinical utility of amyloid imaging in the differential diagnosis of atypical/unclear dementias and its impact on caregivers Alzheimer's & Dementia. 11: P16-P17. DOI: 10.1016/J.Jalz.2015.06.027 |
0.766 |
|
| 2014 |
Langlois M, Doré MC, Laforce R. Thirty Days without a Bite: Wernicke's Encephalopathy in a Patient with Paranoid Schizophrenia. Journal of Neurological Disorders. 2: 182. PMID 27088109 DOI: 10.4172/2329-6895.1000182 |
0.331 |
|
| 2014 |
Bensaïdane MR, M-P F, Damasse G, Chenard M, Dionne C, Duclos M, Bouchard RW, Laforce R. Clinical Utility of Amyloid Imaging in a Complex Case of Corticobasal Syndrome Presenting with Psychiatric Symptoms. Journal of Neurological Disorders. 2: 1-4. PMID 26225355 DOI: 10.4172/2329-6895.1000194 |
0.657 |
|
| 2014 |
Macoir J, Laforce R, Monetta L, Wilson M. [Language deficits in major forms of dementia and primary progressive aphasias: an update according to new diagnostic criteria]. Gã©Riatrie Et Psychologie Neuropsychiatrie Du Vieillissement. 12: 199-208. PMID 24939407 DOI: 10.1684/pnv.2014.0466 |
0.327 |
|
| 2014 |
Beauchemin P, Laforce R. Neurocognitive changes in tertiary neurosyphilis: a retrospective chart review. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 41: 452-8. PMID 24878469 DOI: 10.1017/S0317167100018485 |
0.374 |
|
| 2014 |
Laforce R, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology. Neuroimage. Clinical. 4: 508-16. PMID 24818077 DOI: 10.1016/J.Nicl.2014.03.005 |
0.628 |
|
| 2014 |
Laforce R, Rabinovici GD. Amyloid imaging in atypical dementia. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 186: 695. PMID 24446462 DOI: 10.1503/Cmaj.131158 |
0.542 |
|
| 2014 |
Bergeron D, Verret L, Bouchard RW, Poulin S, Houde M, Fortin M, Laforce R. P2-177: CLINICAL IMPACT OF REPEATED FDG-PET IN THE DIFFERENTIAL DIAGNOSIS OF ATYPICAL DEMENTIAS Alzheimer's & Dementia. 10: P535-P535. DOI: 10.1016/J.Jalz.2014.05.853 |
0.747 |
|
| 2013 |
Burhan AM, Bartha R, Bocti C, Borrie M, Laforce R, Rosa-Neto P, Soucy JP. Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012. Alzheimer's Research & Therapy. 5: S4. PMID 24565285 DOI: 10.1186/Alzrt200 |
0.441 |
|
| 2013 |
Soucy JP, Bartha R, Bocti C, Borrie M, Burhan AM, Laforce R, Rosa-Neto P. Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012. Alzheimer's Research & Therapy. 5: S3. PMID 24565260 DOI: 10.1186/Alzrt199 |
0.428 |
|
| 2013 |
Laforce R. Behavioral and language variants of frontotemporal dementia: a review of key symptoms. Clinical Neurology and Neurosurgery. 115: 2405-10. PMID 24446563 DOI: 10.1016/J.Clineuro.2013.09.031 |
0.388 |
|
| 2013 |
Gaudreau G, Monetta L, Macoir J, Laforce R, Poulin S, Hudon C. Verbal irony comprehension in older adults with amnestic mild cognitive impairment. Neuropsychology. 27: 702-12. PMID 24245931 DOI: 10.1037/A0034655 |
0.659 |
|
| 2013 |
Lamarre AK, Rascovsky K, Bostrom A, Toofanian P, Wilkins S, Sha SJ, Perry DC, Miller ZA, Naasan G, Laforce R, Hagen J, Takada LT, Tartaglia MC, Kang G, Galasko D, et al. Interrater reliability of the new criteria for behavioral variant frontotemporal dementia. Neurology. 80: 1973-7. PMID 23635967 DOI: 10.1212/Wnl.0B013E318293E368 |
0.422 |
|
| 2013 |
Lehmann M, Ghosh PM, Madison C, Laforce R, Corbetta-Rastelli C, Weiner MW, Greicius MD, Seeley WW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain : a Journal of Neurology. 136: 844-58. PMID 23358601 DOI: 10.1093/Brain/Aws327 |
0.683 |
|
| 2013 |
Laforce R, Roy M, Descoteaux M, Berthelot C, Bouchard JP. Neurocognitive deficits and diffusion MR imaging abnormalities in a case of adult-onset autosomal dominant leukodystrophy Translational Neuroscience. 4: 513-515. DOI: 10.2478/S13380-013-0142-1 |
0.345 |
|
| 2013 |
Tardif M, Roy M, Remi B, Laforce R, Verret L, Fortin M, Houde M, Poulin S. P4-103: Months backward test as a reliable predictor of cognitive decline in mild Alzheimer's disease Alzheimer's & Dementia. 9: P741-P742. DOI: 10.1016/J.Jalz.2013.05.1493 |
0.675 |
|
| 2012 |
Laforce R, Kerchner GA, Rabinovici GD, Fong JC, Miller BL, Seeley WW, Grinberg LT. A 44-year-old man with profound behavioural changes. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 39: 527-30. PMID 22728864 DOI: 10.1017/S0317167100014086 |
0.745 |
|
| 2012 |
Macoir J, Hudon C, Bier N, Bouchard R, Houde M, Fortin M, Laforce R, Plante V, Lévesque A. Lexical-Semantic Knowledge about Adjectives is Preserved in Semantic Dementia: Implications for Theoretical Models of Semantic Memory Procedia - Social and Behavioral Sciences. 61: 72-73. DOI: 10.1016/J.Sbspro.2012.10.085 |
0.605 |
|
| 2012 |
Tosun D, Laforce R, Ghosh P, Madison C, Weiner M, Miller B, Jagust W, Rabinovici G. O4-09-05: Multivariate data analysis of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology Alzheimer's & Dementia. 8: P632-P633. DOI: 10.1016/J.Jalz.2012.05.1687 |
0.58 |
|
| 2012 |
Laforce R, Tosun D, Ghosh P, Madison C, Weiner M, Miller B, Jagust W, Rabinovici G. IC-P-120: Multivariate data analysis of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology Alzheimer's & Dementia. 8: P65-P66. DOI: 10.1016/j.jalz.2012.05.154 |
0.467 |
|
| 2011 |
Laforce R, Rabinovici GD. Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications. Alzheimer's Research & Therapy. 3: 31. PMID 22071129 DOI: 10.1186/Alzrt93 |
0.618 |
|
| 2010 |
Laforce R, Buteau JP, Bouchard JP, Rouleau GA, Bouchard RW, Dupré N. Cognitive impairment in ARCA-1, a newly discovered pure cerebellar ataxia syndrome. Cerebellum (London, England). 9: 443-53. PMID 20559786 DOI: 10.1007/S12311-010-0184-7 |
0.665 |
|
| 2010 |
Laforce R, Buteau JP, Paquet N, Verret L, Houde M, Bouchard RW. The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: A retrospective memory clinic study. American Journal of Alzheimer's Disease and Other Dementias. 25: 324-32. PMID 20539026 DOI: 10.1177/1533317510363468 |
0.709 |
|
| 2010 |
Dupré N, Laforce R. Familial Alzheimer disease in Canada. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 37: 302-3. PMID 20481260 DOI: 10.1017/S0317167100010143 |
0.327 |
|
| 2006 |
Sellami L, Meilleur-Durand S, Bergeron D, Verret L, Poulin S, Fortin M, Nadeau Y, Molin P, Macoir J, Hudon C, Bouchard RW, Laforce R. O1-04-06: PREDICTION OF ATYPICAL DEMENTIA SUBTYPES USING A NEW COGNITIVE SCREENING TOOL, THE DÉPISTAGE COGNITIF DE QUÉBEC (DCQ) Alzheimer's & Dementia. 14: P226-P227. DOI: 10.1016/J.Jalz.2018.06.2353 |
0.747 |
|
| 2005 |
Laforce R, McLean S. Knowledge and fear of developing Alzheimer's disease in a sample of healthy adults. Psychological Reports. 96: 204-6. PMID 15825927 DOI: 10.2466/Pr0.96.1.204-206 |
0.343 |
|
| Show low-probability matches. |